Palantir CTO Says Some AI Researchers Are So Sure It Will Cure Cancer They’ve Started 'Smoking' — Warns Both AI Extremes Reflect ‘Social Delusion’

Key takeaways

• Palantir’s CTO cautions that AI hype is often driven by belief rather than evidence, urging a safety‑first approach and challenging the influence of niche groups on AI policy.
• No specific numeric figures were cited in the article.

What happened

Palantir CTO Shyam Sankar warned that extreme optimism and pessimism about AI are driven more by belief systems than evidence, citing researchers who claim AI will cure cancer and even smoke to prove their faith. He described the hype as "mass psychosis" and urged the industry to prove AI’s benefits for national prosperity and security while embedding safety from the start. The comments followed a broader debate over who should steer AI safety, with Sankar criticizing the Effective Altruism…

Why it matters

Sankar’s remarks highlight a growing tension between hype and realistic expectations in AI, especially in high‑stakes fields like healthcare. His critique of the Effective Altruism movement signals a pushback against a small group dictating AI policy, potentially reshaping regulatory and investment priorities. The…

Short-term and longer-term

Short-term. For the next few days, watch PLTR’s stock for any reaction to Sankar’s remarks, as the company’s AI narrative may shift.

Longer-term. Over the coming months, the emphasis on safety and realistic expectations could influence long‑term investment in AI‑enabled healthcare.